Literature DB >> 32042735

Endoscopic ultrasonography guided transgastric trans-portal system fine needle aspiration for diagnosing pancreatic head and uncinate process malignancy.

Min Wang1, Shu Huang2, Rong Pei3, Jie Lin4, Xiujiang Yang3.   

Abstract

BACKGROUND: Endoscopic ultrasonography guided fine needle aspiration (EUS-FNA) is a well-established technique for diagnosing pancreatic malignancy. In general, tissue of pancreatic head and uncinate process lesions is obtained via a transduodenal approach. However, this tissue-acquisition modality is not applicable in cases of pyloric obstruction and duodenal bulb ulceration. The aim of this study is to determine the feasibility and safety of a novel EUS-guided transgastric trans-portal system FNA in the diagnosis of pancreatic head and uncinate process cancer.
METHODS: This study retrospectively analyzed 26 consecutive inpatient patients who had undergone EUS-FNA for highly suspected malignancy of pancreatic head or uncinate process between December 2013 and December 2018. EUS-guided transgastric trans-portal vein (trans-PV, n=2) or trans-superior mesenteric vein (trans-SMV, n=24) FNA was performed in the patients under conscious sedation. Feasibility, diagnostic yield and complication rates of the technique were evaluated.
RESULTS: Specimens obtained by EUS-guided transgastric trans-portal system FNA were adequate for cytological evaluation in all 26 patients. Cytological diagnosis of adenocarcinoma was established in 22 patients, while the remaining 4 patients were negative. The diagnostic accuracy, sensitivity and specificity were 92.3%, 91.7% and 100% respectively. No immediate or delayed procedure-related complications were observed.
CONCLUSIONS: EUS-guided transgastric trans-portal system FNA is a feasible and probably safe method for diagnosing pancreatic head and uncinate process malignancy. Careful selection of the potential candidates and close periprocedural observation are mandatory. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Endoscopic ultrasonography guided fine needle aspiration (EUS-FNA); pancreatic malignancy; transgastric trans-portal system

Year:  2019        PMID: 32042735      PMCID: PMC6989987          DOI: 10.21037/atm.2019.11.137

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  33 in total

1.  Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease.

Authors:  P Vilmann; G K Jacobsen; F W Henriksen; S Hancke
Journal:  Gastrointest Endosc       Date:  1992 Mar-Apr       Impact factor: 9.427

2.  Successful real-time endobronchial ultrasound-guided transbronchial needle aspiration of a hilar lung mass obtained by traversing the pulmonary artery.

Authors:  Brad Vincent; J Terrill Huggins; Peter Doelken; Gerard Silvestri
Journal:  J Thorac Oncol       Date:  2006-05       Impact factor: 15.609

3.  EUS-guided angiography: a novel approach to diagnostic and therapeutic interventions in the vascular system.

Authors:  Priscilla Magno; Chung-Wang Ko; Jonathan M Buscaglia; Samuel A Giday; Sanjay B Jagannath; John O Clarke; Eun Ji Shin; Sergey V Kantsevoy
Journal:  Gastrointest Endosc       Date:  2007-09       Impact factor: 9.427

4.  Transaortic fine-needle aspiration of centrally located lung cancer under endoscopic ultrasound guidance: the final frontier.

Authors:  Michael B Wallace; Timothy A Woodward; Massimo Raimondo; Mohammad Al-Haddad; John A Odell
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

Review 5.  Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review.

Authors:  Kai-Xuan Wang; Qi-Wen Ben; Zhen-Dong Jin; Yi-Qi Du; Duo-Wu Zou; Zhuan Liao; Zhao-Shen Li
Journal:  Gastrointest Endosc       Date:  2011-02       Impact factor: 9.427

Review 6.  EUS-guided FNA of solid pancreas tumors.

Authors:  Muhammad K Hasan; Robert H Hawes
Journal:  Gastrointest Endosc Clin N Am       Date:  2012-04

7.  Endobronchial and Endoscopic Ultrasound-Guided Transvascular Biopsy of Mediastinal, Hilar, and Lung Lesions.

Authors:  Jordan Kazakov; Pravachan Hegde; Mehdi Tahiri; Vicky Thiffault; Pasquale Ferraro; Moishe Liberman
Journal:  Ann Thorac Surg       Date:  2016-11-16       Impact factor: 4.330

8.  Role of repeated endoscopic ultrasound-guided fine needle aspiration in small solid pancreatic masses with previous indeterminate and negative cytological findings.

Authors:  M Tadic; M Kujundzic; T Stoos-Veic; G Kaic; M Vukelic-Markovic
Journal:  Dig Dis       Date:  2009-01-30       Impact factor: 2.404

9.  Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer.

Authors:  Banke Agarwal; Emad Abu-Hamda; Kimber L Molke; Arlene M Correa; Linus Ho
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

10.  Endoscopic Ultrasound Imaging for Differential Diagnosis of Pancreatic Neoplasms: A 7-Year Study in a Chinese Population.

Authors:  Binxin Cui; Weili Fang; Samiullah Khan; Shu Li; Yixiang Chang; Bangmao Wang; Wentian Liu
Journal:  Med Sci Monit       Date:  2018-06-01
View more
  3 in total

1.  Atypical enhanced computed tomography signs of pancreatic cancer and its differential diagnosis from autoimmune pancreatitis.

Authors:  Yong Zhao; Fei Li; Ning An; Zehua Peng
Journal:  Gland Surg       Date:  2021-01

2.  Endoscopic ultrasound-guided transvascular needle biopsy of thoracic and abdominal lesions: a multicenter experience.

Authors:  Albert Garcia-Sumalla; Jose C Subtil; Carlos de la Serna; Sandra Maisterra; Jose Ramon Aparicio; Alejandro Enrique Bojorquez; Rafael Leon Montañes; Enrique Vazquez-Sequeiros; Joan B Gornals
Journal:  Endosc Int Open       Date:  2020-11-27

3.  Effectiveness of introducing a 20-gauge core biopsy needle with a core trap in EUS-FNA/B for diagnosing pancreatic cancer.

Authors:  Shunsuke Watanabe; Jun Miyoshi; Masao Toki; Komei Kambayashi; Shuichi Kitada; Takeshi Nosaka; Tomoyuki Goto; Hirotaka Ota; Kazushige Ochiai; Koichi Gondo; Nobuhito Ikeuchi; Shujiro Tsuji; Kenji Nakamura; Junji Shibahara; Tadakazu Hisamatsu
Journal:  BMC Gastroenterol       Date:  2021-01-06       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.